Sufficient Resources. Upon Mirum’s receipt of the funds contemplated by the Investment Agreements, Mirum will have sufficient resources to conduct the Development of the Compounds and Licensed Product through the end of calendar year 2019.
Appears in 2 contracts
Sources: Assignment and License Agreement, Assignment and License Agreement (Mirum Pharmaceuticals, Inc.)